You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SmartStop: Programmable Transdermal Nicotine Replacement Therapy

    SBC: CHRONO THERAPEUTICS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): According to the Centers for Disease Control and Prevention, cigarette smoking causes the vast majority of lung cancers and over 400,000 deaths annually with a total monetary cost exceeding 190 billion. While the majority of the 45+ million US smokers want to quit, a small fraction of this number actually succeeds. The most popular smoking cessation products u ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Predictive Smoking Cessation Preclinical Battery

    SBC: PGI HOLDING CORPORATION            Topic: NIDA

    DESCRIPTION (provided by applicant): Despite great advances in both the understanding of the neurobiology of addiction and the development and approval of smoking cessation therapies, a significant need remains for better smoking cessation aids. Our goal is aligned with NIDA's intent to bring the power of science to bear on drug abuse and addiction. We propose to use tools from a broad range ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. FIV Testing of a CNS-Relevant Antiretroviral Compound

    SBC: Jericho Sciences, LLC            Topic: NIMH

    DESCRIPTION (provided by applicant): Specific Aims Neurological complications of HIV-1/AIDS persist despite HAART therapies. Current knowledge identifies several sources of neuronal aggravation: (1) direct virus infection of astrocytes and microglial cells; (2) infiltratin of virus-infected monocyte/macrophages; (3) cytokine dysregulation indirectly affecting nerve cells; (4) breakdown of the blo ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Development of Human, Autologous, Pluripotent Very Small Embryonic Like (VSELs) s

    SBC: Caladrius Biosciences            Topic: NIAID

    DESCRIPTION (provided by applicant): In the event of a nuclear accident or terrorist bomb, large numbers of casualties will have been exposed to acute high-dose radiation. Those exposed will have compromised immune systems such that the virulence and infectivity of biological agents is dramatically increased. A compromised immune system exacerbates the effects of infectious agents and may preclu ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Antigen Immunoassay for Diagnosis of Coccidioidomycosis

    SBC: Immuno-mycologics, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Coccidioidomycosis, also known as Valley Fever, is a fungal disease caused by Coccidioides spp. that infects an estimated 150,000 people each year in the United States. Current diagnosis of coccidioidomycosis relieson detection of anti-coccidioidal antibodies in patient sera. However, the sensitivity of this serological assay is particularly low in the firs ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Neutralization of ceramide as a novel approach to specifically inhibit acute GvHD

    SBC: CERAMIDE THERAPEUTICS, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): Acute graft-versus-host disease (GvHD) is a primary complication of allogeneic stem cell transplantation, associated with wasting, immunosuppression and specific damage to the intestines, liver and skin. GvHD results from activation of donor T cells from human leukocyte antigen (HLA)-identical or related donors against host tissues. Current therapeutic approac ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Rapid Assessment of Radiation Exposure

    SBC: Litron Laboratories Ltd            Topic: NIAID

    DESCRIPTION (provided by applicant): Large-scale disaster situations put considerable demands on existing medical infrastructure, as well as local governing and safety agencies. When the additional factor of ionizing radiation and exposure of humans is part of the emergency, the lack of effective assessment tools and management strategies can easily become overwhelming. As part of efforts to devis ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Balancing Disclosure Risk with Inferential Power: Software for Intervalized Data

    SBC: Applied Biomathematics Inc            Topic: NCATS

    DESCRIPTION (provided by applicant): Patient data collected during health care delivery and public health surveys possess a great deal of information that could be used in biomedical and epidemiological research. Access to these data, however, is usually limited because of the private nature of most personal health records. Methods of balancing the informativeness of data for research with the inf ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. An Innovative Cardioprotective

    SBC: Angion Biomedica Corp.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Myocardial infarction (MI) is a significant cause of morbidity and mortality in the U.S. H2 Relaxin (H2R) is a Phase III clinical trial-stage peptide that exhibits both anti-inflammatory and cytoprotective activities which can potentially be harnessed for the treatment of MI via use as adjuvant to recanalization therapy. However, clinical administration of rhH2 ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Social Ecological Model for Community and Home-based Nutrition Education

    SBC: Transcendent International, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Striking changes in dietary patterns and decreases in physical activity have driven the prevalence of obesity among American children to epidemic proportions; low-income and ethnic minority families are especially vulnerable to the socio-economic barriers that influence obesity, with Latino populations being the most severely affected. The proposed interactive, ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government